Full Name
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false


Results 1-20 of 36 (Search time: 0.032 seconds).

Issue DateTitleContributor(s)TypeCat.
12013Professor Maurice Staquet, MD, MS (1930-2013) In MemoriamSolbu, Gabriel; Eeckhoudt, Dominique; Duez, Nicole; Van Glabbeke, Martine; Rotmensz, Nicole; BUYSE, Marc; Dalesio, Otilia; Suciu, Stefan; SYLVESTER, Richard; Renard, Josette; Kirkpatrick, AnneJournal ContributionM
22009Validation of prognostic indices using the frailty modelDUCHATEAU, Luc; JANSSEN, Paul; Ducrocq, V.; SYLVESTER, Richard; LEGRAND, CatherineJournal ContributionA1
32006Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trialvan de Velde, CJH; Therasse, P; DUCHATEAU, Luc; JANSSEN, Paul; SYLVESTER, Richard; LEGRAND, Catherine; van der Hage, JAJournal ContributionA1
42005A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards modelDUCHATEAU, Luc; Ducrocq, V; JANSSEN, Paul; SYLVESTER, Richard; LEGRAND, CatherineJournal ContributionA1
52003The side effects of Bacillus Calmette-Guerin in the treatment of TaT1 bladder cancer do not predict its efficacy: results form a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trialOosterlinck, W.; Hoeltl, W.; SYLVESTER, Richard; van der Meijden, A.P.M.; Bono, A.Journal ContributionA1
62003Does it matter where you are treated? A treatment outcome study based on clinical trial dataDUCHATEAU, Luc; JANSSEN, Paul; SYLVESTER, Richard; LEGRAND, CatherineJournal ContributionM
72002Multicollinearity in prognostic factor analysis using the EORTC QLQ-C30: identification and impact on model selectionMOLENBERGHS, Geert; Curran, Desmond; Kramer, Jocelyn; Van Vreckem, Ann; SYLVESTER, Richard; VAN STEEN, KristelJournal ContributionA1
82002Analysing longitudinal continuous quality of life data with dropoutMOLENBERGHS, Geert; Curran, Desmond; SYLVESTER, Richard; Fossa, S.; Aaronson, N.Journal ContributionA1
92002Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized trialsLamm, D.L.; SYLVESTER, Richard; van der Meijden, A.P.M.Journal ContributionA1
102002Variability in the recurrence rate of first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis or seven EORTC studiesKurth, K.; van der Meijden, A.P.; Witjes, W.A.; Newling, D.; Brausi, M.; Oosterlinck, W.; SYLVESTER, Richard; Collette, L.; Bouffioux, ChristopheJournal ContributionA1
112002The shared frailty model and the power for heterogeneity tests in multicenter trialsDUCHATEAU, Luc; LINDSEY, Patrick; JANSSEN, Paul; SYLVESTER, Richard; LEGRAND, Catherine; NGUTI, RosemaryJournal ContributionA1
122002Treatment outcome studies: pitfalls in curent methods and practiceTherasse, Patrick; DUCHATEAU, Luc; JANSSEN, Paul; SYLVESTER, Richard; LEGRAND, CatherineJournal ContributionA1
131999Orchiectomy and orchiectomy plus mitomycin C for metastatic prostate cancer in patients with poor prognosis: r=the final results of a European organization for research in cancer therapy genitourinary group trialWhelan, P.; Kliment, J.; Rea, L.A.; de Reijke, T.M.; Keuppens, F.I.; Robinson, M.R.G.; SYLVESTER, RichardJournal Contribution
141999Impact of the treating institution on survival of patients with "poor progosis" metastatic nonseminomaLallemand, E.; Stenning, S.P.; Mead, G.M.; Neymark, N.; de Wit, R.; SYLVESTER, Richard; Collette, L.; Kaye, S.B.; Fossa, S.D.; de Mulder, P.H.M.Journal Contribution
151998Four cycles of BEP vs four cycles of VIR in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Groupten Bokkel Huinink, W.W.; Sleijfer, D.T.H.; Stoter, G.; de Prijck, L.; de Wit, R.; SYLVESTER, Richard; Collette, L.; Neijt, J.P.Journal Contribution
161998Serum alpha-fetoprotein surge after the iniation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significanceten Bokkel Huinink, W.W.; Stoter, G.; van Oosterom, A.T.; Boven, E.; de Wit, R.; SYLVESTER, Richard; Collette, L.; Kaye, S.B.; Sleijfer, D.T.; de Mulder, P.H.M.Journal Contribution
171998Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a randomized Medical Research Council/European Organization for Research and Treatment of Cancer studyCullen, M.; Lallemand, E.; Mead, G.M.; de Prijck, L.; van Groeningen, C.; Stenning, S.; Bodrogi, I.; de Wit, R.; SYLVESTER, Richard; Kaye, S.B.; Fossa, S.; Collette, L.Journal Contribution
181998Identifying the types of missingness in quality of life data from clinical trialsHsu Schmitz, Shu-Fang; MOLENBERGHS, Geert; Curran, Desmond; SYLVESTER, Richard; Bacchi, M.Journal Contribution
191997An introduction to the statistical design of phase III cancer clinical trialsSYLVESTER, RichardJournal Contribution
201997Does isoniazed reduce side effects of intravesical Bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of EORTC protocol 30911de Balincourt, C.; Brausi, M.; Holtl, W.; SYLVESTER, Richard; Vegt, P.; van der Meijden, A.Journal Contribution